Clinical Trial Update: Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)

View source ↗

Summary

Special Drug Use Investigation for ADOAIR (fluticasone/salmeterol) completed, sponsor GlaxoSmithKline reports.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ADOAIR (fluticasone propionate/salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Respiratory Disorders | Status: COMPLETED